Cranberry Juice and Warfarin: When Bad Publicity Trumps Science
Abstract
Based on anecdotal reports, the question of whether cranberry juice interacts with warfarin has been raised. This article discusses the potential mechanism, and systematically reviews case reports as well as clinical trials examining the possible interaction. We systematically searched MEDLINE via PubMed, and the Cochrane Library database. Fifteen case reports were summarized, including the initial unpublished brief reports to the Committee on Safety of Medicines and the subsequent 6 published case reports. Seven clinical trials were analyzed, including 3 studies using warfarin and 4 surrogate drugs. Only 2 cases had a validation scale suggesting a “probable” interaction, but even in these patients there were many reasons to question the validity of a relevant drug interaction. Randomized clinical trials and surrogate markers found no evidence to support the interaction between cranberry juice and warfarin. Because the moderate consumption of cranberry juice does not affect anticoagulation, we encourage the reexamination of initial warnings based on scientific evidence. We conclude that the initial precautionary warnings by administrating bodies are limited to anecdotal case reports and represent misleading conclusions.
Requests for reprints should be addressed to Jack Ansell, MD, Lenox Hill Hospital, 6 Black Hall, 100 East 77th Street, New York, NY 10075
Funding: There was no sponsor for this study.
Conflict of Interest: Jennifer Zikria, none; Raimonda Goldman, none; a prior study by Jack Ansell was supported in part by a grant from the Ocean Spray Co., and he has been a consultant for the Cranberry Institute of America.
Authorship: Jennifer Zikria performed a literature search, created tables, performed data interpretation for case reports and clinical trials, and wrote the manuscript. Raimonda Goldman performed data interpretation for case reports and reviewed the manuscript. Jack Ansell reviewed, modified, and edited the manuscript.